NovaBridge Biosciences (NBP) Return on Equity (2020 - 2025)

NovaBridge Biosciences (NBP) has 6 years of Return on Equity data on file, last reported at 0.0% in Q2 2025.

• Return on Equity for Q2 2025 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was 0.0% (changed N/A YoY), and the FY2024 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity fell to 0.0% in Q2 2025 per NBP's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Equity peaked at 0.0% in Q3 2024 and troughed at 0.0% in Q2 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Equity.
• On a YoY basis, Return on Equity climbed as much as 0 bps in 2021 and fell as far as 0 bps in 2021.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then surged by 143 bps to 0.0% in 2022, then plunged by 137 bps to 0.0% in 2023, then jumped by 232 bps to 0.0% in 2024, then plunged by 137 bps to 0.0% in 2025.
• Business Quant data shows NBP's Return on Equity at 0.0% in Q2 2025, 0.0% in Q1 2025, and 0.0% in Q4 2024.